The results in rodent models of atherosclerosis are not interchangeable

The influence of diet and strain


      The determinant factors for the development of atherosclerosis in response to dietary cholesterol were examined in two animal models to assess the comparability of results. We studied 128 male Apo E−/− and 128 LDLr−/− mice randomly assigned to baseline (n = 8) and 5 groups (n = 24 each) that differed only in their dietary fat and cholesterol supplements. At 10, 16, 24 and 32 weeks of age, 8 animals from each group were sequentially sacrificed and the variables analyzed. The lesion sizes changed at different rates but they were predictable and did not differ in complexity. We observed, however, significant differences between strains, particularly in the constitutive expression of liver genes, their metabolic response to dietary cholesterol, their feeding behaviour, their glucose tolerance and the gain in body weight. Both strains presented characteristics that resemble steatohepatitis but manifestations were more severe in LDLr−/− mice. The divergent responses indicate that the choice of the diet and the model should be carefully considered in atherosclerosis studies and extrapolations interpreted with caution.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Libby P.
        Inflammation in atherosclerosis.
        Nature. 2002; 420: 868-874
        • Tous M.
        • Ferre N.
        • Camps J.
        • Riu F.
        • Joven J.
        Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis.
        Mol Cell Biochem. 2005; 268: 53-58
        • Daugherty A.
        • Rateri D.L.
        Development of experimental designs for atherosclerosis studies in mice.
        Methods. 2005; 36: 129-138
        • Breslow J.L.
        Mouse models of atherosclerosis.
        Science. 1996; 272: 685-688
        • Zhang S.H.
        • Reddick R.L.
        • Piedrahita J.A.
        • Maeda N.
        Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.
        Science. 1992; 258: 468-471
        • Plump A.S.
        • Smith J.D.
        • Hayek T.
        • et al.
        Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.
        Cell. 1992; 71: 343-353
        • Ishibashi S.
        • Goldstein J.L.
        • Brown M.S.
        • Herz J.
        • Burns D.K.
        Massive xanthomatosis and atherosclerosis in cholesterol-fed low-density lipoprotein receptor-negative mice.
        J Clin Invest. 1994; 93: 1885-1893
        • Osada J.
        • Joven J.
        • Maeda N.
        The value of apolipoprotein E knockout mice for studying the effects of dietary fat and cholesterol on atherogenesis.
        Curr Opin Lipidol. 2000; 11: 25-29
        • Calleja L.
        • Paris M.A.
        • Paul A.
        • et al.
        Low-cholesterol and high-fat diets reduce atherosclerotic lesion development in ApoE-knockout mice.
        Arterioscler Thromb Vasc Biol. 1999; 10: 2368-2375
        • Lichtman A.H.
        • Clinton S.K.
        • Iiyama K.
        • et al.
        Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate.
        Arterioscler Thromb Vasc Biol. 1999; 8: 1938-1944
        • Nakashima Y.
        • Plump A.S.
        • Raines E.W.
        • Breslow J.L.
        • Ross R.
        ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
        Arterioscler Thromb. 1994; 1: 133-140
        • Ishibashi S.
        • Herz J.
        • Maeda N.
        • Goldstein J.L.
        • Brown M.S.
        The two-receptor model of lipoprotein clearance: tests of the hypothesis in “knockout” mice lacking the low-density lipoprotein receptor, apolipoprotein E, or both proteins.
        Proc Natl Acad Sci USA. 1994; 91: 4431-4435
        • Vergnes L.
        • Phan J.
        • Strauss M.
        • Tafuri S.
        • Reue K.
        Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression.
        J Biol Chem. 2003; 278: 42774-42784
        • Tous M.
        • Ferre N.
        • Rull A.
        • et al.
        Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice.
        Biochem Biophys Res Commun. 2006; 340: 1078-1084
        • Veillard N.R.
        • Steffens S.
        • Burger F.
        • Pelli G.
        • Mach F.
        Differential expression patterns of proinflammatory and anti-inflammatory mediators during atherogenesis in mice.
        Arterioscler Thromb Vasc Biol. 2004; 24: 2339-2344
        • Wuttge D.M.
        • Sirsjo A.
        • Eriksson P.
        • Stemme S.
        Gene expression in atherosclerotic lesion of ApoE deficient mice.
        Mol Med. 2001; 7: 383-392
        • Targher G.
        • Bertolini L.
        • Padovani R.
        • et al.
        Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients.
        J Endocrinol Invest. 2006; 29: 55-60
        • Escola-Gil J.C.
        • Julve J.
        • Marzal-Casacuberta A.
        • et al.
        Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
        J Lipid Res. 2000; 41: 1328-1338
        • Paigen B.
        • Morrow A.
        • Holmes P.A.
        • Mitchell D.
        • Williams R.A.
        Quantitative assessment of atherosclerotic lesions in mice.
        Atherosclerosis. 1987; 68: 231-240
        • Repa J.J.
        • Turley S.D.
        • Lobaccaro J.A.
        • et al.
        Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.
        Science. 2000; 289: 1524-1529
        • Dietschy J.M.
        • Turley S.D.
        Control of cholesterol turnover in the mouse.
        J Biol Chem. 2002; 277: 3801-3804
        • Gan J.
        • Katagiri H.
        • Ishigaki Y.
        • et al.
        Involvement of Apolipoprotein E in excess fat accumulation and insulin resistance.
        Diabetes. 2007; 56: 24-33
        • Schreyer S.A.
        • Vick C.
        • Lystig T.
        • Mystkowsky P.
        • Leboeuf R.
        LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice.
        Am J Physiol Endocrinol Metab. 2002; 282: E207-E214
        • Merat S.
        • Casanada F.
        • Sutphin M.
        • Palinski W.
        • Reaven P.
        Western-type diets induce insulin resistance in LDL receptor deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet.
        Arterioscler Thromb Vasc Biol. 1999; 19: 1223-1230
        • Damas J.K.
        • Boullier A.
        • Waehre T.
        • et al.
        Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy.
        Arterioscler Thromb Vasc Biol. 2005; 25: 2567-2572
        • Chi H.
        • Messas E.
        • Levine R.A.
        • Graves D.T.
        • Amar S.
        Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications.
        Circulation. 2004; 110: 1678-1685
        • Ogletree M.L.
        Overview of physiological and pathophysiological effects of thromboxane A2.
        Fed Proc. 1987; 46: 133-138
        • Marshall S.
        The hexosamine-signalling pathway: a new road to drug discovery.
        Curr Opin Endocrinol Diabetes. 2002; 9: 160-167
        • Lee C.H.
        • Olson P.
        • Hevener A.
        • et al.
        PPARδ regulates glucose metabolism and insulin sensitivity.
        PNAS. 2006; 103: 3444-3449